Dermata Therapeutics, Inc. Common Stock
$1.16
Market Cap
$5.75M
Shares Outstanding
5.0M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Aug 13, 2021
Round Lot
100
Locale
US
Day Open
$1.18
Day High
$1.19
Day Low
$1.14
Volume
5.6K
VWAP
$1.16
Prev Close
$1.16
Transactions
--
Acc. Volume
--
Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions. It focuses on leveraging prior clinical and technical expertise to develop OTC treatments for conditions such as acne, psoriasis, rosacea, and seborrheic dermatitis. The company is currently developing a once-weekly acne treatment system that utilizes an active ingredient from the OTC monograph in combination with the company's Spongilla technology. It intends to apply its Spongilla technology platform across a range of dermatologic and aesthetic skin applications, including intradermal delivery of botulinum toxin. The company's operates in one segment, which is the business of developing, branding, marketing, and commercializing direct to consumer skincare products.
Dermata Therapeutics, Inc. Common Stock (DRMA) closed the 2026-09-18 session at $1.16, up 0.00% versus the previous close (+0.00). The stock opened at $1.18 and traded between $1.14 and $1.19 during that session. Session trading volume was 6K shares. The volume-weighted average price (VWAP) is $1.16.
Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions. It focuses on leveraging prior clinical and technical expertise to develop OTC treatments for conditions such as acne, psoriasis, rosacea, and seborrheic dermatitis. The company is currently developing a once-weekly acne treatment system that utilizes an active ingredient from the OTC monograph in combination with the company's Spongilla technology. It intends to apply its Spongilla technology platform across a range of dermatologic and aesthetic skin applications, including intradermal delivery of botulinum toxin. The company's operates in one segment, which is the business of developing, branding, marketing, and commercializing direct to consumer skincare products.
Dermata Therapeutics, Inc. Common Stock has a market capitalization of $5.7 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. DRMA is listed on the XNAS exchange. The company employs approximately 9 people. Dermata Therapeutics, Inc. Common Stock is headquartered in SAN DIEGO, CA. The recorded listing date is 2021-08-13.
On this page you can find market DRMA stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.